Insider · CIK 0001578965

Koppel Adam

Reports to the SEC for 16 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001578965

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-20	KLRAKailera Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+16.9M sh	—	—	16,875,000
2026-04-20	KLRAKailera Therapeutics, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−4.15M sh	—	—	0
2026-04-20	KLRAKailera Therapeutics, Inc. · Series A-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−16.9M sh	—	—	0
2026-04-20	KLRAKailera Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+1.56M sh	$16.00	+$25M	22,583,268
2026-04-20	KLRAKailera Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+4.15M sh	—	—	21,020,768
2026-04-16	KLRAKailera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+38.3K sh	—	—	38,300
2024-08-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−80.2K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−65.7M sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−3,282 sh	—	—	10,461
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−10.5K sh	—	—	0
2024-06-26	FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award	Director	AAward	+16K sh	$5.52	+$88.3K	16,000
2024-06-05	Cerevel Therapeutics Holdings, Inc.A Award	Director, 10% Owner	AAward	+10.5K sh	—	—	13,743
2024-01-11	SLDBSolid Biosciences Inc.A Award	Director, 10% Owner	AAward	+904K sh	$5.53	+$5M	4,034,582
2023-10-16	Cerevel Therapeutics Holdings, Inc.P Purchase	Director, 10% Owner	PPurchase	+5.48M sh	$22.81	+$125M	65,679,781
2023-06-21	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2023-06-07	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+13.8K sh	—	—	13,780
2023-06-07	Cerevel Therapeutics Holdings, Inc.A Award	Director, 10% Owner	AAward	+3,282 sh	—	—	3,282
2023-06-07	Cerevel Therapeutics Holdings, Inc.J Other	Director, 10% Owner	JOther	−433K sh	—	—	60,199,729
2023-06-06	SLDBSolid Biosciences Inc. · Director Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+9,650 sh	—	—	9,650
2022-12-13	SLDBSolid Biosciences Inc. · Director Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+9,650 sh	—	—	9,650
2022-12-02	SLDBSolid Biosciences Inc. · Director Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+2,666 sh	—	—	2,666
2022-06-21	FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2022-06-14	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+23.5K sh	—	—	23,459
2022-05-26	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+40K sh	—	—	40,000
2021-12-28	Dicerna Pharmaceuticals IncU Disposition from Tender	Director	UDisposition from Tender	−3.08M sh	$38.25	−$118M	0
2021-12-28	Dicerna Pharmaceuticals IncRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,333 sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncU Disposition from Tender	Director	UDisposition from Tender	−3,333 sh	$38.25	−$127K	0
2021-07-13	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,530
2021-06-16	SLDBSolid Biosciences Inc. · Director Stock Option (Right To Buy)A Award	Director, 10% Owner	AAward	+30K sh	—	—	30,000
2021-06-10	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+43K sh	—	—	42,950
2021-06-03	Dicerna Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+3,333 sh	—	—	3,333
2021-06-03	Dicerna Pharmaceuticals IncRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,333 sh	—	—	0
2021-06-03	Dicerna Pharmaceuticals IncDirector Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-06-03	Dicerna Pharmaceuticals IncRestricted Stock UnitsA Award	Director	AAward	+3,333 sh	—	—	3,333
2021-05-27	Aptinyx Inc.Stock Option(Right Buy)A Award	Director, 10% Owner	AAward	+40K sh	—	—	40,000
2021-03-23	SLDBSolid Biosciences Inc.A Award	Director, 10% Owner	AAward	+870K sh	$5.75	+$5M	7,929,918
2020-12-31	Aptinyx Inc.Stock Option (Right Buy)A Award	Director, 10% Owner	AAward	+5,508 sh	$2.22	+$12.2K	5,508
2020-12-10	SLDBSolid Biosciences Inc.A Award	Director, 10% Owner	AAward	+3.19M sh	$3.70	+$11.8M	7,060,353
2020-12-10	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−1M sh	$23.40	−$23.4M	3,080,237
2020-11-09	Cerevel Therapeutics Holdings, Inc.P Purchase	Director, 10% Owner	PPurchase	+332K sh	$10.30	+$3.42M	60,632,356
2020-10-27	Cerevel Therapeutics Holdings, Inc.P Purchase	Director, 10% Owner	PPurchase	+10M sh	$10.00	+$100M	60,300,063
2020-10-27	Cerevel Therapeutics Holdings, Inc.J Other	Director, 10% Owner	JOther	+50M sh	—	—	50,300,063
2020-10-26	BCLS Acquisition Corp.A Award	Director, 10% Owner	AAward	+488K sh	$10.00	+$4.88M	487,500
2020-09-30	Aptinyx Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+5,663 sh	$2.16	+$12.2K	5,663

Recent filings

Accepted (ET)
Apr 204
Koppel Adam0001193125-26-164407
SEC(opens sec.gov)
Aug 54
Koppel Adam0000950170-24-090903
SEC(opens sec.gov)
Jun 284
Koppel Adam0001562180-24-005356
SEC(opens sec.gov)
Jun 74
Koppel Adam0000950170-24-070855
SEC(opens sec.gov)
Jan 124
Koppel Adam0000950170-24-004276
SEC(opens sec.gov)
Oct 184
Koppel Adam0000899243-23-019971
SEC(opens sec.gov)
Jun 224
Koppel Adam0001562180-23-005476
SEC(opens sec.gov)
Jun 94
Koppel Adam0000899243-23-015220
SEC(opens sec.gov)
Jun 84
Koppel Adam0000950170-23-027058
SEC(opens sec.gov)
Dec 154
Koppel Adam0000899243-22-038700
SEC(opens sec.gov)

Companies

Address

C/O BAIN CAPITAL LIFE SCIENCES INVESTORS LLC 200 CLARENDON STREET

BOSTON, MA, 02116